Revolution Medicines, Warrant Stock Performance
| RVMDW Stock | 0.32 0.08 20.00% |
Revolution Medicines, holds a performance score of 15 on a scale of zero to a hundred. The company holds a Beta of 1.73, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Revolution Medicines, will likely underperform. Use Revolution Medicines, treynor ratio, expected short fall, as well as the relationship between the Expected Short fall and day median price , to analyze future returns on Revolution Medicines,.
Risk-Adjusted Performance
15 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Revolution Medicines, Warrant are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating fundamental indicators, Revolution Medicines, showed solid returns over the last few months and may actually be approaching a breakup point. ...more
1 | Belite Delights Investors, Soleno, ADMA, Harrow Deliver Triple-digit Gains, Keep An Eye On Oculis - RTTNews | 10/09/2024 |
2 | Revolution Medicines Secures Massive 862.5M in Upsized Public Offering RVMD Stock News - StockTitan | 12/05/2024 |
| Begin Period Cash Flow | 163.1 M |
Revolution |
Revolution Medicines, Relative Risk vs. Return Landscape
If you would invest 8.00 in Revolution Medicines, Warrant on September 11, 2024 and sell it today you would earn a total of 24.00 from holding Revolution Medicines, Warrant or generate 300.0% return on investment over 90 days. Revolution Medicines, Warrant is currently producing 4.4803% returns and takes up 22.6524% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than Revolution, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Revolution Medicines, Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Revolution Medicines,'s investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Revolution Medicines, Warrant, and traders can use it to determine the average amount a Revolution Medicines,'s price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1978
| Best Portfolio | Best Equity | RVMDW | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 22.65 actual daily | 96 96% of assets are less volatile |
Expected Return
| 4.48 actual daily | 89 89% of assets have lower returns |
Risk-Adjusted Return
| 0.2 actual daily | 15 85% of assets perform better |
Based on monthly moving average Revolution Medicines, is performing at about 15% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Revolution Medicines, by adding it to a well-diversified portfolio.
Revolution Medicines, Fundamentals Growth
Revolution Stock prices reflect investors' perceptions of the future prospects and financial health of Revolution Medicines,, and Revolution Medicines, fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Revolution Stock performance.
| Return On Equity | -0.47 | ||||
| Return On Asset | -0.29 | ||||
| Operating Margin | (845.95) % | ||||
| Revenue | 11.58 M | ||||
| EBITDA | (430.58 M) | ||||
| Net Income | (436.37 M) | ||||
| Total Debt | 87.94 M | ||||
| Book Value Per Share | 9.34 X | ||||
| Cash Flow From Operations | (350.57 M) | ||||
| Total Asset | 2.06 B | ||||
| Retained Earnings | (1.14 B) | ||||
| Working Capital | 1.74 B | ||||
About Revolution Medicines, Performance
Evaluating Revolution Medicines,'s performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Revolution Medicines, has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Revolution Medicines, has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.22) | (0.23) | |
| Return On Capital Employed | (0.25) | (0.27) | |
| Return On Assets | (0.21) | (0.22) | |
| Return On Equity | (0.24) | (0.25) |
Things to note about Revolution Medicines, performance evaluation
Checking the ongoing alerts about Revolution Medicines, for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Revolution Medicines, help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Revolution Medicines, is way too risky over 90 days horizon | |
| Revolution Medicines, has some characteristics of a very speculative penny stock | |
| Revolution Medicines, appears to be risky and price may revert if volatility continues | |
| Revolution Medicines, has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 11.58 M. Net Loss for the year was (436.37 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Revolution Medicines, generates negative cash flow from operations | |
| Revolution Medicines, has a poor financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Revolution Medicines Secures Massive 862.5M in Upsized Public Offering RVMD Stock News - StockTitan |
- Analyzing Revolution Medicines,'s financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Revolution Medicines,'s stock is overvalued or undervalued compared to its peers.
- Examining Revolution Medicines,'s industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Revolution Medicines,'s management team can have a significant impact on its success or failure. Reviewing the track record and experience of Revolution Medicines,'s management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Revolution Medicines,'s stock. These opinions can provide insight into Revolution Medicines,'s potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Revolution Stock Analysis
When running Revolution Medicines,'s price analysis, check to measure Revolution Medicines,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revolution Medicines, is operating at the current time. Most of Revolution Medicines,'s value examination focuses on studying past and present price action to predict the probability of Revolution Medicines,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revolution Medicines,'s price. Additionally, you may evaluate how the addition of Revolution Medicines, to your portfolios can decrease your overall portfolio volatility.